Felix earned his undergraduate degree in Chemistry from Texas A&M University and his PhD in Chemical Biology from Johns Hopkins University. He began his career at Booz Allen Hamilton, where he supported operational and data strategy initiatives for the FDA and NIH. He subsequently transitioned into private equity, working with KKR before spending five years at Blackstone, where he managed operational initiatives across the firm’s life sciences and Asia businesses. Late last year, Felix returned to Houston after several years in Singapore and joined JPMorgan’s Innovation Economy team, where he supports early-stage and venture-backed life sciences and healthcare companies across Texas and parts of the Southwest.